XORTX Therapeutics Inc. ("XORTX " or the “Company ”) (NASDAQ: XRTX \| TSXV: XRTX \| Frankfurt: ANU), a late stage clinical p ...

The School of Arts & Humanities, School of Engineering, and School of Business Management of St Aloysius (Deemed to be ...

Whatever the eventual fate of software companies, there may be tactical trade opportunities in this out-of-favour sector ...

The 8th edition of the Singapore Biennale prompts you to wonder whether displacement releases the wild or brings it under further control ...

The two new lenses introduce a new era of precision for architectural and landscape photography, combining an ultra-wide 104° angle of view with unparalleled perspective control. Your vision, ...

Boasting 40 meetups a month and a broad estimated community of 55,000 bitcoiners, the Bitcoin Indonesia ecosystem might be one of the most active and successful Bitcoin adoption stories in the world ...

Circular RNAs (circRNAs), a class of covalently closed, non-coding RNAs, have recently emerged as crucial regulators of gene expression. They exert their roles through microRNA (miRNA) sponging, ...

Abstract: This paper investigates the role of digital technologies as Circular Economy enablers. We review extant literature to identify fifteen digital technologies and characterize their enabling ...

July 16 - As we approach the United Nation’s 30th climate conference, COP30, to be held in Belem, Brazil this November, the need for nations to transition from a linear to a circular economy has never ...

The new AI function in Sheets can generate text for groups of cells based on their contents. The new AI function in Sheets can generate text for groups of cells based on their contents. is a news ...

Researchers at University of California San Diego School of Medicine have developed a gene therapy for Alzheimer’s disease that could help protect the brain from damage and preserve cognitive function ...

Predicting nodal burden after neoadjuvant chemotherapy (NAC) with circulating tumor (ct)DNA for surgical planning: Results from the I-SPY2 trial. DFS 536+279 60.9 / 63.0 / 66.3 73.9 / 79.1 / 82.1 DRFI ...